Skip to main content

Presponse SQ (Canada)

This treatment applies to the following species:
Company: Boehringer Ingelheim Animal Health

Mannheimia Haemolytica Toxoid

BEEF & DAIRY

Presponse SQ Indications

This product has been shown to be effective for the vaccination of healthy cattle 3 months of age or older against Mannheimia haemolytica. The duration of immunity has not been determined. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

Directions and dosage: Mix well before use. Inject one 2 mL dose subcutaneously in the neck area, anterior to the shoulder, using aseptic technique. Contact your veterinarian or the manufacturer for information on revaccination frequency.

Precautions

Store out of direct sunlight at 2-8°C. Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Transient injection site reactions may occur. In case of anaphylactoid reaction, administer epinephrine. This product has not been tested in pregnant animals. In case of human exposure, contact a physician.

Preservative: Thimerosal.

For use in animals only.

PRESPONSE® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc., used under license.

Manufactured by:

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Tel.: 1 (888) 637-4251

VLN/PCN 124/8699.01

Distributed by:

Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4

50 doses/100 mL

157506-01

CPN: 1182229.0

BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
5180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4
Customer Care No.:   1-800-567-1885
Technical Services No.:   1-877-565-5501
Website:   www.boehringer-ingelheim.ca
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.

Animalytix

Copyright © 2025 Animalytix LLC. Updated: 2025-03-02